Navigation Links
Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
Date:8/18/2008

based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relation Contacts:

Oramed Pharmaceuticals

Eric Rosenberg

Cell: +972-54-566-7713

Office: +972-2-566-0001

Email: eric@oramed.com

Media Contacts:

Ruder Finn Israel for Oramed

Matthew Krieger

Cell: +972-54-467-6950

Office: +972-2-589-2003

Email: matthew@oramed.com


'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
2. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
6. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
7. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
9. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
10. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
11. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ... of Global Biologic Drug Discovery Outsourcing Market" report ... discovery outsourcing market will likely grow in a CAGR ... $11.4 B by 2020. It has been ... become a new but important type of medication. They ...
(Date:7/7/2015)... -- Dedicated to promoting wellness and giving back to its ... purple pledge in support of Alzheimer,s & Brain-Awareness Month. ... time to shine a purple light for the millions ... in our community who are affected by Alzheimer,s. Raising ... helps mobilize friends, family members, neighbors and coworkers to ...
(Date:7/7/2015)... , July 7, 2015 The ... USD 1,197.7 million by 2020, growing at an estimated CAGR ... study by Grand View Research, Inc. Introduction of innovative technologies ... with growing awareness levels pertaining to the advantages of breast ... next six years. In addition, presence of untapped growth opportunities ...
Breaking Medicine Technology:Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
(Date:7/7/2015)... , ... July 07, 2015 , ... ... MRI services, is debuting their brand new website. The website’s goal is to ... a wider selection of patient tools, including requesting appointments online. , Part of ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers ... Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for ... who have sex with men (MSM) and transgender women, the groups at highest ...
(Date:7/7/2015)... ... 2015 , ... Quadrino Law Group is pleased to announce the relocation of ... The new facility is a state of the art building, located with easy ... firm's CEO and founder, said, "We are pleased to service our clients from such ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today ... to access its antibody combination therapy (ACT) technology platform. The platform has ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Summer is a ... precautions, however, so Amica Insurance is sharing some safety tips. , Jean Tapley, senior ... gardening: , Leisure activities/sports, , Start slowly. Going from no ...
Breaking Medicine News(10 mins):Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Amica Insurance Has 7 Summer Safety Tips 2
... the Regenstrief Institute have developed an automated system to ... needs of each patient in the short time allotted ... Primary Care Screening in Pediatric Waiting Rooms," in the ... by personalizing and automating the patient screening process and ...
... are the place where an estimated 30 percent of Americans die, ... better job at managing end of life care. A new ... is starting a discussion over the need to create end ... provide nursing homes with incentive to improve care. "Nursing homes ...
... 2012) Cancer is much more likely in the elderly than ... the disease and the often-toxic side effects of treatment. ... at The University of Texas Health Science Center at San Antonio ... in younger patients can be used to help the elderly, with ...
... When women at high risk of breast cancer ... they were more likely to make a choice about ... new study finds. Researchers developed a web-based tool ... about breast cancer and personalized information about an individual ...
... CORAL GABLES, FL (April 13, 2012) Women undergoing treatment ... and improve psychological well-being by staying off the couch. ... women who are physically active during treatment have less ... less debilitating fatigue. , "Women who are physically ...
... (HealthDay News) -- Single baby boomers generally have poorer health ... says. The first of the 79 million baby boomers ... reached age 65 in 2011. About one-third of baby boomers ... or because they never married. Researchers examined national data ...
Cached Medicine News:Health News:IU, Regenstrief automated system aims to improve child health 2Health News:IU, Regenstrief automated system aims to improve child health 3Health News:Study recommends ways to evaluate end-of-life care in nursing homes 2Health News:Study recommends ways to evaluate end-of-life care in nursing homes 3Health News:Immunotherapy for elderly cancer patients finds new promise in drug combination 2Health News:Immunotherapy for elderly cancer patients finds new promise in drug combination 3Health News:Decision guide reduced uncertainty over breast cancer prevention, study finds 2
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: